UNSPSC 51201619: Rubella virus vaccine

This classification denotes a vaccine that addresses that acute infectious disease caused by the rubella virus, of type species of rubivirus causing acute infection in humans, primarily children and young adults, and which enters the respiratory tract via airborne droplet and spreads to the lymphatic system.

UNSPSC 51201619 Rubella virus vaccine is a Commodity code that encompasses viral immunization products procured by state health departments and related public health authorities. The scope covers finished vaccine formulations—in this code's case, rubella virus vaccine and related viral vaccines such as yellow fever vaccine—that state and local public health agencies purchase for immunization programs, disease prevention initiatives, and public health response. State health departments serve as the primary issuing bodies under this code, typically acting through their purchasing or procurement divisions to acquire vaccines for statewide distribution and administration. Purchase notices in this category are commonly sole-source or limited-source procurements given the specialized nature of vaccine manufacturing, regulatory requirements, and the small number of approved vendors for each vaccine type.

The Mississippi State Department of Health posted a sole-source procurement notice on July 13, 2026 for Yellow Fever Vaccine from Sanofi Pasteur, Inc., with an objection deadline of August 3, 2026. The notice invites third parties to challenge the sole-source classification by demonstrating that alternative vendors can supply the vaccine; if substantiated objections are received, the department will conduct a competitive bid process. The notice does not disclose quantity, contract term, or estimated value. Recent activity under this code remains limited to state health department solicitations, with no multi-state or multi-jurisdiction campaigns evident in current postings.